Vitango film-coated tablets 200 mg blister No. 20

Instructions for Vitango film-coated tablets 200 mg blister No. 20

Composition

active ingredient: dry extract of rhodiola rosea roots (Rhodiola rosea);

1 film-coated tablet contains dry extract of rhodiola rosea roots (Rhodiola rosea) (1.5-5:1) 200 mg (extractant: ethanol 60% (m/m));

excipients: microcrystalline cellulose, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, hypromellose, stearic acid, red iron oxide (E 172), titanium dioxide (E 171), antifoam emulsion: simethicone, methylcellulose, sorbic acid.

Dosage form

Film-coated tablets.

The main physical and chemical properties: round tablets covered with a red film coating.

Pharmacotherapeutic group

Tonics. ATX code A13A.

Pharmacological properties

Pharmacodynamics

Rhodiola rosea extract WS® 1375 is an adaptogen that allows the body to adapt to stressful conditions. It exhibits its adaptogenic properties by modulating the hypothalamic-pituitary-adrenal axis, which plays a primary role in organizing the body's response to stress. In addition, Vitango normalizes the level and activity of neurotransmitters in the central nervous system. Thus, it eliminates stress-induced disorders of appetite, locomotor activity and sexual function in animals, and also improves cellular energy production by increasing the level of adenosine triphosphate.

Clinical studies of Vitango show clinically significant relief of stress-related symptoms such as physical and mental fatigue, exhaustion, irritability, mood and concentration impairment after 4-8 weeks of treatment. A clinical study of 12 weeks of treatment revealed the ability of the drug to increase individual stress tolerance, and consequently reduce the risk of developing burnout. The ability of Vitango to prevent stress was confirmed in another study after 12 weeks of treatment, which positively affected attention and the allocation of mental resources in individuals at risk for stress symptoms.

Pharmacokinetics

Data is missing.

Indication

It is used as an adaptogenic agent to prevent and relieve mental and physical symptoms of stress and overwork (fatigue, neurasthenia, vegetative-vascular dystonia, irritability, tension).

Contraindication

Hypersensitivity to the active substance or to any component of the drug. Pregnancy and lactation.

Interaction with other medicinal products and other types of interactions

There are no data on interactions.

Application features

The drug is not recommended for use in patients with impaired liver or kidney function due to lack of relevant data.

Ability to influence reaction speed when driving vehicles or other mechanisms

Does not affect.

Use during pregnancy or breastfeeding

Contraindicated.

Method of administration and doses

Adults should take 1 tablet twice a day (morning and afternoon) 30 minutes before meals with a glass of water. The duration of treatment is determined by the doctor individually.

Children

The drug is not recommended for use in children (under 18 years of age).

Overdose

No cases of overdose have been identified.

Adverse reactions

Hypersensitivity reactions and hypoglycemia are possible. If you experience any undesirable symptoms, you should consult a doctor.

Expiration date

5 years.

Do not use after the expiry date stated on the packaging.

Storage conditions

Does not require any special storage conditions. Keep out of the reach of children.

Packaging

20 tablets in a blister, 2 blisters in a cardboard box.

Vacation category

Without a prescription.

Producer

Dr. Wilmar Schwabe GmbH & Co. KG.

Location of the manufacturer and its business address

Wilmar-Schwabe-Strasse 4, 76227 Karlsruhe, Germany.